Schering-Plough
SGP
#508
Rank
S$59.42 B
Marketcap
N/A
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Schering-Plough was a major American pharmaceutical company that developed and marketed a range of prescription drugs. In 2009, Schering-Plough was acquired by Merck & Co. in a $41 billion USD deal.

Revenue for Schering-Plough (SGP)

Revenue in 2008: S$23.80 Billion

In 2008 the company made a revenue of S$23.80 Billion.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Schering-Plough from 1996 to 2008

Annual revenue

Year Revenue Change
2008S$23.80 B
2006S$13.63 B11.42%
2005S$12.23 B14.94%
2004S$10.64 B-0.74%
2003S$10.72 B-18.13%
2002S$13.09 B3.86%
2001S$12.61 B-0.13%
2000S$12.62 B6.96%
1999S$11.80 B13.61%
1998S$10.39 B19.16%
1997S$8.72 B19.84%
1996S$7.27 B